AXR vs EQIX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak fundamental health with a Piotroski F-Score of 3/9, indicating significant financial distress risks. Despite strong profitability margins and a debt-free balance sheet, the business is experiencing sharp declines in revenue and earnings, with YoY earnings down 70.7%. The stock trades below its Graham Number of $33.48 but at a premium to its growth-adjusted intrinsic value of $13.51, suggesting overvaluation given deteriorating fundamentals. Persistent negative earnings surprises and lack of analyst coverage further undermine confidence.
EQIX shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
AXR vs EQIX: Head-to-Head Comparison
This page compares AMREP Corporation (AXR) and Equinix, Inc. (EQIX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.